[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:castleman-disease":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":26,"states":27},"Castleman Disease",3,[7,14,20],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT02817997","International Registry for Patients With Castleman Disease",[],"RECRUITING","2026-08-26T02:17:16.126291Z","2026-05-13T02:55:06.100975Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":18,"content_modified":19},"NCT03717844","Registry for Adults With Plasma Cell Disorders (PCD's)",[],"2026-08-26T02:18:13.438956Z","2026-05-13T02:55:06.175931Z",{"nct_id":21,"title":22,"phases":23,"status":11,"updated_at":24,"content_modified":25},"NCT03300830","Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease",[],"2026-08-26T02:19:08.862440Z","2026-05-13T02:55:06.121750Z",[],[]]